7091 - 7100 of 8826 Results
Title
Year
- The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies2017RESTRICTEDTitle: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 5Start Page: 726End Page: 738Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26964Citation Count: 65
- Tau/α‐synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study2017RESTRICTEDTitle: Tau/α‐synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1066End Page: 1073Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27001Citation Count: 48
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 167
-
OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27232Citation Count: 146
- Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease2018RESTRICTEDTitle: Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 3Start Page: 431End Page: 439Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27284Citation Count: 37
- Hoehn and Yahr stage 3 and postural stability item in the movement disorder society–unified Parkinson's disease rating scale2018RESTRICTEDTitle: Hoehn and Yahr stage 3 and postural stability item in the movement disorder society–unified Parkinson's disease rating scaleJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 7Start Page: 1188End Page: 1189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27453Citation Count: 7
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6544441Citation Count: 136
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)2018RESTRICTEDTitle: Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Journal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 1Start Page: 67End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27492Citation Count: 203
-
OPENTitle: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 536End Page: 544Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27646Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27646Citation Count: 260
-
OPENTitle: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic DevelopmentJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27818Best OA location URL: https://doi.org/10.1002/mds.27818Citation Count: 84